(Total Views: 221)
Posted On: 04/04/2017 12:36:44 PM
Post# of 15624
I absolutely agree $10 by 2018 is conservative.
Considering we should have SEVERAL creams on the market by end of 2017 and a Sublingual Tablet... I definitely feel it's NOT crazy to predict $12.50 - $17.25 by end of year.
That's "only" $1.8B - $2.5B as a Market Cap. More and more proven revenue will continue to help. Positive Multiple Myeloma updates will greatly help.
I say this because of GWPH's $3.25B Market Cap with weak revenue ($14M, I believe?) and only ONE approved product currently -- and a product with far fewer possible patients.
Considering we should have SEVERAL creams on the market by end of 2017 and a Sublingual Tablet... I definitely feel it's NOT crazy to predict $12.50 - $17.25 by end of year.
That's "only" $1.8B - $2.5B as a Market Cap. More and more proven revenue will continue to help. Positive Multiple Myeloma updates will greatly help.
I say this because of GWPH's $3.25B Market Cap with weak revenue ($14M, I believe?) and only ONE approved product currently -- and a product with far fewer possible patients.
(2)
(0)
